← SynDRA
L-778123 FREE BASE
SynDRA canonical compound SYN0001396 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | FNTA | FNTB | PGGT1B |
|---|
| Mechanism of action | farnesyltransferase inhibitor |
|---|
All known targets
- PGGT1B
- FNTA
- FNTB
- FNTB; FNTA
Mechanisms of action (all sources)
- farnesyltransferase inhibitor
- Modulator
- PGGT1B MODULATOR
Cross-references
Synonyms
- L-778123
- L 778123
- L 778,123
- RefChem:151776
- 2A2059P49U
- L778123
- C22H20ClN5O
- UNII-31ZXM8ZKQ3
- L-778,123 free base
- ClC-1 inhibitor compound A-3
- orb1697179
- SCHEMBL1683541
- L-778,123 (free base)
- SCHEMBL31237533
- 1s63
- 1s64
- CHEBI:180478
- GLXC-07294
- BDBM50097071
- MFCD00951568
- T3182L
- AKOS037652409
- NCGC00508850-03
- DA-08984
- DS-20244
- HY-16273
- CS-0006277
- NS00072632
- BRD-K10958118-003-01-5
- (S)-2-(4-Bromo-2-(1,1-difluoropropyl)phenoxy)propionic acid
- 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE
- AC1L50Q0
- L-778123 Hcl
- 4-((5-((4-(3-chlorophenyl)-3-oxopiperazin-1-yl)methyl)-1H-imidazol-1-yl)methyl)benzonitrile
- L-778,123 hydrochloride
- L-778,123
- CHEMBL279433
- 31ZXM8ZKQ3
Look up L-778123 FREE BASE in the interactive SynDRA portal →